Hypertension, transforming growth factor-β, angiotensin II and kidney disease

Journal of Hypertension

Volumn 22, Issue 7, 2004, Pages 1265-1267

  Bobik, Alex ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRIL; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; BIOACCUMULATION; DIABETES MELLITUS; DISEASE MARKER; EDITORIAL; ENZYME ACTIVITY; HUMAN; HYPERTENSION; KIDNEY DISEASE; MOLECULAR DYNAMICS; NEPHROSCLEROSIS; NICK END LABELING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 3042754866     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000125468.35523.7b     Document Type: Editorial

References (25)

1. 1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9:964-968.
2. Dai C, Yang J, Liu Y. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem 2003; 278:12537-12545.
3. Okado T, Terada Y, Tanaka H, Inoshita S, Nakao A, Sasaki S. Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells. Kidney Int 2002; 62:1178-1186.
4. Yu L, Border WA, Huang Y, Nobel NA. TGF-beta isoforms in renal fibrogenesis. Kidney Int 2003; 64:844-856.
5. Hugo C, Kang DH, Johnson RJ. Sustained expression of thrombospondin-1 is associated with the development of glomerular and tubulointerstitial fibrosis in the remnant kidney model. Nephron 2002; 90:460-470.
6. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transitions. EMBO J 2004; 23:1155-1165.
7. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, et al. Inhibition of renal fibrosis by gene transfer of inducible smad7 using ultrasound-microbubble system in the rat UUO model. J Am Soc Nephrol 2003; 14:1535-1548.
8. Yuan W, Varga J. Transforming growth factor-beta repression of matrix metalloproetinase-1 in dermal fibroblasts involves Smad3. J Biol Chem 2001; 276:38501-38510.
9. Dai C, Yang J, Liu Y. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem 2003; 278:12537-12545.
10. Shihab FS, Bennett WM, Yi H, Andoh TF. Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporin nephrotoxicity. Am J Transplant 2002; 2:111-119.
11. 1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112:1486-1494.
12. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells. Kidney Int 2003; 63:464-473.
13. Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998; 31:181-188.
14. Pimentel JL, Sundell CL, Wang S, Kopp JB, Montero A, Martinez-Maldonado M. Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney Int 1995; 48:1233-1246.
15. Shin GT, Kim SJ, Ma KA, Kim HS, Kim D. ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans. Am J Kidney Dis 2000; 36:894-902.
16. Liao J, Kopbayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, et al. J Nephrol 2003; 16:841-849.
17. Nakamura Y, Ono H, Zhou X, Frohlich ED. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N-nitro-L-arginine methyl ester/spontaneously hypertensive rats. Hypertension 2001; 37:1262-1267.
18. Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED. Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Hypertension 2001; 38:1300-1306.
19. 1 inhibition in spontaneously hypertnesive rats. J Hypertens 2004; 22:1389-1395.
20. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta in rat glomerular mesangial cells. J Clin Invest 1994; 93:2431-2437.
21. Miyajima A, Chen J, Kirman I, Poppas DP, Darracott Vaughan E, Felsen D. Interaction of nitric oxide and transforming growth factor-beta1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urol 2000; 164:1729-1734.
22. Chua CC, Diglio CA, Siu BB, Chua BH. Angiotensin II induces TGF-beta1 production in rat heart endothelial cells. Biochim Biophys Acta 1994; 1223:141-147.
23. Mori T, Cowley AW. Role of pressure in angiotensin II-induced renal injury. Hypertension 2004; 43:752-759.
24. Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, et al. Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol 2003; 14:1816-1824.
25. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, et al. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 2002; 62:58-64.